Publications by authors named "Outi Paija"

Claim this Profile
I
Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trial.
Antonio Llombart, Antonio Frassoldati, Outi Paija, Harm Peter Sleeboom, Guy Jerusalem

Clin Breast Cancer· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola-Vuorinen, Minna Tanner, Outi Paija

J Clin Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report.
Pia Vihinen, Outi Paija, Atte Kivisaari, Leena Koulu, Heikki Aho

J Med Case Rep· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaemia: a rare but neglected problem among Finnish patients receiving chemotherapy for solid tumours.
Pirkko-Liisa Kellokumpu-Lehtinen, Ulla Puistola, Outi Paija, Eeva Taimela, Outi Hirvonen

Support Care Cancer· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial.
Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola-Vuorinen, Minna Tanner, Outi Paija

Lancet Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Pirkko Kellokumpu-Lehtinen, Ulla Puistola, Outi Paija, Eeva Taimela, Outi Hirvonen

Duodecim· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entacapone increases levodopa exposure and reduces plasma levodopa variability when used with Sinemet CR.
Outi Paija, Kari Laine, Eeva-Riitta Kultalahti, Mika Leinonen, Risto Huupponen

Clin Neuropharmacol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Does a doctor care about a cancer patient's pain?].
Outi Paija

Duodecim· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum bone markers in breast cancer patients during 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy.
Marita E H Kailajärvi, Eeva K Salminen, Outi M M Paija, Arja M Virtanent, Aila E Leino

Anticancer Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administration.
Risto Huupponen, Outi Paija, Markku Salonen, Harry Björklund, Juha Rouru

Drugs R D· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis